Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.
about
Natural History and Clinical Consequences of Hepatitis B Virus InfectionHepatocellular carcinoma--cause, treatment and metastasis.Occult hepatitis B virus infection and its clinical implications.Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention.Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China.Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analoguesTumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma.Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression.Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.The association of complex liver disorders with HBV genotypes prevalent in PakistanIncidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologiesBetel quid chewing as a risk factor for hepatocellular carcinoma: a case-control studyIndividualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus.Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.Influence of polymorphisms in the Wnt/β-catenin pathway genes on hepatocellular carcinoma risk in a Chinese Han population.Insulin-like growth factor II in hepatocellular carcinoma.Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma.Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis.Modelling the past, current and future HCV burden in France: detailed analysis and perspectives.Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis.Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy.Natural history of compensated cirrhosis in the Child-Pugh class A compared between 490 patients with hepatitis C and 167 with B virus infections.Analysis of HCV-IG isotype complexes by a novel immuno-capture RT-PCR method.Improvement of long-term outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era.High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis.Recent progress and new trends in the treatment of hepatitis B.Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma: a pilot study of patients with hepatitis B virus-related cirrhosis.Analysis of complement-bound hepatitis B virus complexes by an immuno-capture polymerase chain reaction method.Effects of metallothionein-1 genetic polymorphism and cigarette smoking on the development of hepatocellular carcinoma.Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection.Risk factors for recurrence after curative resection of hepatitis C-related hepatocellular carcinoma in patients without postoperative interferon therapy.Treatment with potentially hepatotoxic drugs and the risk of hepatocellular carcinoma: results of a european case - control study.hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents
P2860
Q24810151-56BC3F9E-2DBD-42BB-B64D-7A10F460A48CQ34512068-0E8577A8-AC64-445E-B629-9FEE62BB1226Q34703532-EBB16022-7B04-412A-BD35-BF4799C3C825Q34733981-8C8A5C08-EB7A-41FD-B553-3F4EA6FDA8D4Q35173805-D8531ACA-FBB2-4784-A3A6-9841F874BF3FQ35668724-713FE5CE-ED6A-47EF-B6F1-09457101B22DQ36143638-0510DCCB-79DA-40E7-8D67-C19FF9913C03Q36157148-E799C9F6-31A5-4C35-8C90-02C369ECBE67Q36360813-E5807C37-862E-4A1C-AE5F-EECBEF3DCED4Q36402124-04C977F7-ED64-4D55-A5AE-823BE55264D3Q36438943-C5AEC473-83F6-4726-8AD5-28FE7D24785EQ36622692-92734009-182A-4B83-BE4D-1CB0F179932AQ36699256-4D37B28F-9676-462E-8619-AE79EC35BA8AQ37356370-E3515599-59CF-4EF2-B31F-D25E586234FEQ37578500-E8EEB58A-8AC7-4473-9F96-85F0CA0A04B4Q37727203-F4764B97-8A1A-4C91-AB46-3A2344735CB0Q37755101-501EDADA-CFF0-45A4-8EF0-E092FB9737DBQ38266863-CDBCCFBD-CC6E-453F-8EC2-A35FD17FACA2Q39000508-C41A34C5-BF15-437F-8006-EBAC6615B74FQ40024651-98D3CE56-4176-4635-B5B8-8D76CFC20758Q40363491-A09FB470-BDED-441A-8386-7BBA45C245BAQ42980390-421D0AFD-BD49-4A04-AE9C-CE46275D9541Q42998329-833798FD-C2D5-48E9-BCC9-44987FC45CB0Q43034304-05EF7C4F-42FD-4EA2-AFE2-F6916C683660Q43035805-88294B64-2DFA-4F10-9E1D-D77F4274A7C4Q43923526-D2DAA2F5-0EFF-4EBD-9DC7-0C02DE34445CQ44062995-978F4450-2B85-4F7B-863F-0F87463F438CQ45407427-34BDDDDC-EE62-41D9-BEDE-FA3FF42D9032Q45722811-7CCCF3D1-FDB2-4B8B-BC9E-AA83FE08EB06Q46095668-B94275CD-F292-4C23-8A20-4ABEE8BE0CE1Q47582698-B067A37A-E7AC-40F3-96DF-E98CACEFDD71Q50493122-1FB8619A-759C-4687-85AE-879F96174787Q52914532-90BD9A1C-6E50-452C-99BF-628B0B7FC485Q57301080-EF4BD4C1-2103-4B79-AC77-024AABD9FDD1
P2860
Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Effect of hepatitis C and B vi ...... arcinoma: a prospective study.
@ast
Effect of hepatitis C and B vi ...... arcinoma: a prospective study.
@en
type
label
Effect of hepatitis C and B vi ...... arcinoma: a prospective study.
@ast
Effect of hepatitis C and B vi ...... arcinoma: a prospective study.
@en
prefLabel
Effect of hepatitis C and B vi ...... arcinoma: a prospective study.
@ast
Effect of hepatitis C and B vi ...... arcinoma: a prospective study.
@en
P2093
P2860
P356
P1476
Effect of hepatitis C and B vi ...... arcinoma: a prospective study.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1997.493
P407
P577
1997-01-01T00:00:00Z